TrialAntimicrobial agents and chemotherapy2014

Identification of the NS5B S282T resistant variant and two novel amino acid substitutions that affect replication capacity in hepatitis C virus-infected patients treated with mericitabine and danoprevir.

Xiao Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.